Literature DB >> 21532878

Successful treatment of palmoplantar hyperkeratotic psoriasis with a combination of etanercept and alitretinoin.

Volker Meyer1, Tobias Goerge, Thomas A Luger, Stefan Beissert.   

Abstract

Palmoplantar hyperkeratotic psoriasis can be challenging to treat since micro-trauma induced by manual labor supports the development of new lesions via the isomorphic Koebner reaction. In this article, the authors report the successful treatment of severe palmoplantar hyperkeratotic psoriasis with etanercept and alitretinoin combination therapy. The results indicate that the new retinoid alitretinoin can be effectively used in combination with anti-tumor necrosis factor blocking agents for the treatment of psoriasis in individual cases.

Entities:  

Year:  2011        PMID： 21532878      PMCID： PMC3084611     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN： 1941-2789


  6 in total

1.  Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial.

Authors:  Thomas Ruzicka; Frederik Grønhøj Larsen; Dorota Galewicz; Attila Horváth; Peter Jan Coenraads; Kristian Thestrup-Pedersen; Jean Paul Ortonne; Christos C Zouboulis; Martin Harsch; Thomas C Brown; Maurice Zultak
Journal:  Arch Dermatol       Date:  2004-12

2.  9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes.

Authors:  Jihong Xu; Paul D Drew
Journal:  J Neuroimmunol       Date:  2005-11-21       Impact factor: 3.478

3.  Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial.

Authors:  Alice Gottlieb; Alan Menter; Alan Mendelsohn; Yaung-Kaung Shen; Shu Li; Cynthia Guzzo; Scott Fretzin; Rod Kunynetz; Arthur Kavanaugh
Journal:  Lancet       Date:  2009-02-11       Impact factor: 79.321

4.  Palmoplantar lesions in psoriasis: a study of 3065 patients.

Authors:  Bhushan Kumar; Abir Saraswat; Inderjeet Kaur
Journal:  Acta Derm Venereol       Date:  2002       Impact factor: 4.437

Review 5.  Alitretinoin: a comprehensive review.

Authors:  Caleb Cheng; Jason Michaels; Noah Scheinfeld
Journal:  Expert Opin Investig Drugs       Date:  2008-03       Impact factor: 6.206

6.  Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways.

Authors:  Rajan P Nair; Kristina Callis Duffin; Cynthia Helms; Jun Ding; Philip E Stuart; David Goldgar; Johann E Gudjonsson; Yun Li; Trilokraj Tejasvi; Bing-Jian Feng; Andreas Ruether; Stefan Schreiber; Michael Weichenthal; Dafna Gladman; Proton Rahman; Steven J Schrodi; Sampath Prahalad; Stephen L Guthery; Judith Fischer; Wilson Liao; Pui-Yan Kwok; Alan Menter; G Mark Lathrop; Carol A Wise; Ann B Begovich; John J Voorhees; James T Elder; Gerald G Krueger; Anne M Bowcock; Gonçalo R Abecasis
Journal:  Nat Genet       Date:  2009-01-25       Impact factor: 38.330
  6 in total
  5 in total

Review 1.  [Off-label use of alitretinoin].

Authors:  K Fritz; G S Tiplica; C Salavastru; M Onder
Journal:  Hautarzt       Date:  2013-10       Impact factor: 0.751

Review 2.  The Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review.

Authors:  Isabelle M Sanchez; Eric Sorenson; Ethan Levin; Wilson Liao
Journal:  Dermatol Ther (Heidelb)       Date:  2017-11-15

Review 3.  Evidence and Suggested Therapeutic Approach in Psoriasis of Difficult-to-treat Areas: Palmoplantar Psoriasis, Nail Psoriasis, Scalp Psoriasis, and Intertriginous Psoriasis.

Authors:  Nilendu Sarma
Journal:  Indian J Dermatol       Date:  2017 Mar-Apr       Impact factor: 1.494

4.  Alitretinoin in Dermatology-An Update.

Authors:  Aditya Kumar Bubna
Journal:  Indian J Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.494

5.  Two Cases of Successful Treatment of Refractory Chronic Inflammatory Skin Disease, Atopic Dermatitis and Psoriasis with Oral Alitretinoin.

Authors:  Jee Hee Son; Sook Young Park; Yong Se Cho; Yun Sun Byun; Bo Young Chung; Hee Jin Cho; Hye One Kim; Chun Wook Park
Journal:  Ann Dermatol       Date:  2017-06-21       Impact factor: 1.444
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.